Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LGVN | US
0.06
3.09%
Healthcare
Biotechnology
30/06/2024
16/10/2024
2.00
1.94
2.00
1.93
Longeveron Inc. a clinical stage biotechnology company develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B an allogeneic medicinal signaling cell therapy product isolated from the bone marrow of young healthy adult donors. It is conducting Phase 1 Phase 2a and Phase 2b clinical trials in various indications such as aging-related frailty alzheimer's disease metabolic syndrome acute respiratory distress syndrome and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami Florida.
View LessStrength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
55.2%1 month
42.4%3 months
86.2%6 months
242.1%-
-
1.72
0.12
0.09
-49.61
12.27
-
-17.22M
28.72M
28.72M
-
-747.86
-
115.70
-142.16
1.60
6.01
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.26
Range1M
0.48
Range3M
3.12
Rel. volume
1.10
Price X volume
897.51K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Marker Therapeutics Inc | MRKR | Biotechnology | 3.52 | 31.41M | 7.65% | n/a | 0.00% |
ProMIS Neurosciences Inc. | PMN | Biotechnology | 1.04 | 31.08M | 2.02% | n/a | 0.00% |
Akari Therapeutics Plc | AKTX | Biotechnology | 2.52 | 30.60M | -1.21% | n/a | -27.01% |
DarT Bioscience Inc | DARE | Biotechnology | 3.58 | 30.60M | 2.87% | 0.10 | 218.34% |
BriaCell Therapeutics Corp. Common Shares | BCTX | Biotechnology | 0.8383 | 30.04M | -6.82% | n/a | 0.00% |
TPST | TPST | Biotechnology | 1.11 | 30.03M | -5.13% | n/a | 119.58% |
Kala Pharmaceuticals Inc | KALA | Biotechnology | 5.26 | 28.83M | 1.15% | n/a | 268.29% |
SABS | SABS | Biotechnology | 3.11 | 28.70M | 28.51% | n/a | 11.58% |
ImmuCell Corporation | ICCC | Biotechnology | 3.56 | 27.89M | 0.28% | n/a | 67.52% |
Fortress Biotech Inc | FBIOP | Biotechnology | 5.18 | 27.81M | 3.60% | n/a | 494.61% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.5 | 19.04M | 4.17% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.02 | 18.42M | 2.01% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.6542 | 9.49M | -5.19% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2051 | 3.68M | -6.82% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.09 | 2.84M | -0.91% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -0.99% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.42 | 0 | 2.63% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.21 | 0 | 3.19% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.5 | 0 | 1.42% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.05 | 0 | 6.06% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -49.61 | 0.53 | Cheaper |
Ent. to Revenue | 12.27 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 1.72 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 86.25 | 72.92 | Par |
Debt to Equity | 0.12 | -1.24 | Expensive |
Debt to Assets | 0.09 | 0.25 | Cheaper |
Market Cap | 28.72M | 3.78B | Emerging |